Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
Kamran MA Aziz Aseer Diabetes Center, Aseer Central Hospital, Ministry of Health, Abha, Saudi Arabia Abstract: Diabetes management during Ramadan fasting is challenging to the physician in terms of minimizing the risk of hypoglycemia. As compared to oral hypoglycemic agents (OHAs) and sulfonylureas...
Guardado en:
Autor principal: | Aziz KMA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce42027a5dff45f9a689e17a89fda098 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
por: AlMaatouq MA
Publicado: (2012) -
Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
por: Al Sifri S
Publicado: (2012) -
Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
por: Hassoun AAK, et al.
Publicado: (2016) -
Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
por: Nishio S, et al.
Publicado: (2015) -
Self-Monitoring of Blood Glucose and Hypoglycemia Association During Fasting in Ramadan Among Patients with Diabetes
por: Mansouri D, et al.
Publicado: (2020)